INR 49.26
(3.05%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.98 Billion INR | -35.24% |
2022 | 3.91 Billion INR | 5.48% |
2021 | 3.71 Billion INR | 23.72% |
2020 | 3 Billion INR | 22.08% |
2019 | 2.46 Billion INR | 7.1% |
2018 | 2.29 Billion INR | 16.24% |
2017 | 1.97 Billion INR | 2.97% |
2016 | 1.91 Billion INR | 28.54% |
2015 | 1.49 Billion INR | 3.15% |
2014 | 1.44 Billion INR | -2.48% |
2013 | 1.48 Billion INR | 6.91% |
2012 | 1.38 Billion INR | 3.05% |
2011 | 1.34 Billion INR | 10.12% |
2010 | 1.22 Billion INR | 82.84% |
2009 | 669.26 Million INR | -6.41% |
2008 | 715.1 Million INR | -10.52% |
2007 | 799.15 Million INR | 0.57% |
2006 | 794.6 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 635.58 Million INR | 38.23% |
2023 Q1 | 1.21 Billion INR | 25.99% |
2023 FY | 2.53 Billion INR | -35.24% |
2023 Q4 | 600.28 Million INR | -53.96% |
2023 Q3 | 1.3 Billion INR | 5.93% |
2023 Q2 | 1.23 Billion INR | 1.25% |
2022 Q3 | 1.04 Billion INR | -1.26% |
2022 Q1 | 853.08 Million INR | -13.13% |
2022 Q2 | 1.05 Billion INR | 23.97% |
2022 FY | 3.91 Billion INR | 5.48% |
2022 Q4 | 964.94 Million INR | -7.59% |
2021 FY | 3.71 Billion INR | 23.72% |
2021 Q3 | 1.05 Billion INR | 20.35% |
2021 Q4 | 982.01 Million INR | -6.6% |
2021 Q1 | 808.98 Million INR | -2.57% |
2021 Q2 | 873.59 Million INR | 7.99% |
2020 Q2 | 853.59 Million INR | 28.65% |
2020 FY | 3 Billion INR | 22.08% |
2020 Q1 | 663.51 Million INR | 26.78% |
2020 Q4 | 830.32 Million INR | 4.2% |
2020 Q3 | 796.84 Million INR | -6.65% |
2019 FY | 2.46 Billion INR | 7.1% |
2019 Q1 | 610.15 Million INR | 13.22% |
2019 Q2 | 667.03 Million INR | 9.32% |
2019 Q3 | 659.87 Million INR | -1.07% |
2019 Q4 | 523.36 Million INR | -20.69% |
2018 Q3 | 631.01 Million INR | 11.29% |
2018 FY | 2.29 Billion INR | 16.24% |
2018 Q2 | 567.01 Million INR | 1.55% |
2018 Q4 | 538.91 Million INR | -14.6% |
2018 Q1 | 558.34 Million INR | 5.53% |
2017 Q3 | 474.75 Million INR | -0.44% |
2017 Q4 | 529.08 Million INR | 11.44% |
2017 FY | 1.97 Billion INR | 2.97% |
2017 Q1 | 495.97 Million INR | 0.0% |
2017 Q2 | 476.84 Million INR | -3.86% |
2016 FY | 1.91 Billion INR | 28.54% |
2015 FY | 1.49 Billion INR | 3.15% |
2014 FY | 1.44 Billion INR | -2.48% |
2013 FY | 1.48 Billion INR | 6.91% |
2012 Q1 | - INR | 0.0% |
2012 FY | 1.38 Billion INR | 3.05% |
2012 Q2 | - INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2011 FY | 1.34 Billion INR | 10.12% |
2010 FY | 1.22 Billion INR | 82.84% |
2009 FY | 669.26 Million INR | -6.41% |
2008 FY | 715.1 Million INR | -10.52% |
2007 FY | 799.15 Million INR | 0.57% |
2006 FY | 794.6 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 87.476% |
Aurobindo Pharma Limited | 39.23 Billion INR | 94.935% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 82.927% |
Granules India Limited | 7.18 Billion INR | 72.329% |
Indoco Remedies Limited | 4.74 Billion INR | 58.148% |
Achyut Healthcare Limited | 1.6 Million INR | -123420.82% |
Ajanta Pharma Limited | 30.46 Billion INR | 93.476% |
Alkem Laboratories Limited | 32.83 Billion INR | 93.947% |
Alpa Laboratories Limited | 156.14 Million INR | -1172.807% |
Brooks Laboratories Limited | 51.18 Million INR | -3783.255% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 23.571% |
Bajaj HealthCare Limited | 985.34 Million INR | -101.701% |
Bliss GVS Pharma Limited | 1.41 Billion INR | -40.038% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.927% |
Eris Lifesciences Limited | 4.94 Billion INR | 59.792% |
FDC Limited | 5.34 Billion INR | 62.841% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 97.058% |
Gufic Biosciences Limited | 1.07 Billion INR | -84.414% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 6.437% |
Ipca Laboratories Limited | 13.91 Billion INR | 85.717% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -156.972% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -4205.941% |
Lasa Supergenerics Limited | 291.17 Million INR | -582.564% |
Laurus Labs Limited | 3.01 Billion INR | 33.989% |
Lupin Limited | 95.67 Billion INR | 97.923% |
Mankind Pharma Limited | 23.15 Billion INR | 91.416% |
Medicamen Biotech Limited | 335.16 Million INR | -492.973% |
Medico Remedies Limited | 161.84 Million INR | -1128.004% |
Megasoft Limited | 49.52 Million INR | -3912.781% |
NATCO Pharma Limited | 10.05 Billion INR | 80.24% |
Piramal Pharma Limited | 19.91 Billion INR | 90.02% |
RPG Life Sciences Limited | 1.63 Billion INR | -21.519% |
Sigachi Industries Limited | 579.88 Million INR | -242.731% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.711% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -41.678% |
Syncom Formulations (India) Limited | 942.39 Million INR | -110.893% |
Unichem Laboratories Limited | 6.72 Billion INR | 70.451% |
Wanbury Limited | 1.16 Billion INR | -71.195% |
Windlas Biotech Limited | 1 Billion INR | -97.46% |
ZIM Laboratories Limited | 1.01 Billion INR | -96.183% |
Zydus Lifesciences Limited | 43.17 Billion INR | 95.397% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 35.405% |
Divi's Laboratories Limited | 14.17 Billion INR | 85.974% |
Hester Biosciences Limited | 908.84 Million INR | -118.68% |
Procter & Gamble Health Limited | 2.99 Billion INR | 33.65% |
Amrutanjan Health Care Limited | 1.09 Billion INR | -80.844% |
Bal Pharma Limited | 389.89 Million INR | -409.746% |
Strides Pharma Science Limited | 9.16 Billion INR | 78.308% |
Venus Remedies Limited | 1.91 Billion INR | -3.714% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 35.355% |
Nectar Lifesciences Limited | 625.55 Million INR | -217.712% |
Shilpa Medicare Limited | 2.18 Billion INR | 8.857% |
Aarti Drugs Limited | 1.16 Billion INR | -70.234% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -80.875% |
Suven Life Sciences Limited | 109.75 Million INR | -1710.888% |
Ind-Swift Limited | 946.56 Million INR | -109.964% |
Valiant Laboratories Limited | 36.28 Million INR | -5376.728% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 76.388% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 56.603% |
Themis Medicare Limited | 782.85 Million INR | -153.872% |
Hikal Limited | 2.48 Billion INR | 20.065% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 90.722% |
Sequent Scientific Limited | 2.9 Billion INR | 31.51% |
Novartis India Limited | 470.1 Million INR | -322.772% |
Wockhardt Limited | 6.4 Billion INR | 68.946% |
Jubilant Pharmova Limited | 14.45 Billion INR | 86.25% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -12160.869% |
Neuland Laboratories Limited | 2.92 Billion INR | 32.163% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -381.891% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | -193.938% |